Emily Hammad Mrig, PhD
@dr-emily-mrig.bsky.social
Assistant Professor, Center for Translational and Policy Research on Precision Medicine (TRANSPERS), UCSF. Research focused on how insurance and health policy shapes precision medicine access. #precisionmedicine #genetics #UCSF #healthequity #healthpolicy
🧬 Just published!
Our UCSF_TRANSPERS team explored perspectives on how payers can help solve genomic testing implementation challenges. Key insight? Payers and stakeholders agree: insurers can (and should) be part of the solution.
Read our full paper: bit.ly/3XqJXi6
@kathrynp-phd.bsky.social
Our UCSF_TRANSPERS team explored perspectives on how payers can help solve genomic testing implementation challenges. Key insight? Payers and stakeholders agree: insurers can (and should) be part of the solution.
Read our full paper: bit.ly/3XqJXi6
@kathrynp-phd.bsky.social
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions | JCO Precision Oncology
PURPOSEGenomic testing is crucial in cancer risk identification, diagnosis, and treatment.
However, health care implementation is challenging, even for tests covered by insurance.
US payers are import...
ascopubs.org
March 3, 2025 at 9:26 PM
🧬 Just published!
Our UCSF_TRANSPERS team explored perspectives on how payers can help solve genomic testing implementation challenges. Key insight? Payers and stakeholders agree: insurers can (and should) be part of the solution.
Read our full paper: bit.ly/3XqJXi6
@kathrynp-phd.bsky.social
Our UCSF_TRANSPERS team explored perspectives on how payers can help solve genomic testing implementation challenges. Key insight? Payers and stakeholders agree: insurers can (and should) be part of the solution.
Read our full paper: bit.ly/3XqJXi6
@kathrynp-phd.bsky.social